Cortex News and Research

RSS

Dopamine replacement therapy causes brain dysfunction in patients with Parkinson disease, study says

People with Parkinson's Disease are more likely to display abnormal social behaviour and make poor decisions in ambiguous circumstances if they are pathological gamblers, according to research in the January issue of the European Journal of Neurology.

18 Jan 2010

Reducing DA dosage causes acute withdrawal symptoms in Parkinson's patients

New research has shown that reducing the dosage of dopamine agonist (DA) drugs, a mainstay treatment for Parkinson's disease (PD), sometimes causes acute withdrawal symptoms similar to those reported by cocaine addicts -- including anxiety, panic attacks, depression, sweating, nausea, generalized pain, fatigue, dizziness and drug cravings. These symptoms can be severe, and are not alleviated by other PD medications.

12 Jan 2010

Functional disconnection between brain regions in ADHD children

Two brain areas fail to connect when children with attention deficit hyperactivity disorder attempt a task that measures attention, according to researchers at the UC Davis Center for Mind and Brain and M.I.N.D. Institute.

12 Jan 2010

Combination of advanced techniques in robotics and neuroscience shows promise for stroke patients

Bioengineers have taken a small step toward improving physical recovery in stroke patients by showing that a key feature of how limb motion is encoded in the nervous system plays a crucial role in how new motor skills are learned.

8 Jan 2010

Tel Aviv University finds Mozart's music induces weight gain in premature babies

The music they listen to doesn't have any lyrics that tell them to grow, but new research from Tel Aviv University finds that premature babies who are exposed to music by 18th-century composer Wolfgang Amadeus Mozart gain weight faster -- and therefore become stronger -- than those who don't.

7 Jan 2010

Perturbing DISC1 gene could help researchers treat mental illness, says study

Scientists have long eyed mutations in a gene known as DISC1 as a possible contributor to schizophrenia and mood disorders, including depression and bipolar disorder. Now, new research led by Johns Hopkins researchers suggests that perturbing this gene during prenatal periods, postnatal periods or both may have different effects in mice, leading to separate types of brain alterations and behaviors with resemblance to schizophrenia or mood disorders.

6 Jan 2010

Ben-Gurion University researcher defines integrated interpretation of ASD

A researcher from Ben-Gurion University of the Negev has defined a new, integrated interpretation of Autism Spectrum Disorders (ASD), which makes it easier to understand both the commonalities and differences between ASD and other conditions.

5 Jan 2010

Citicoline supplements may reduce cravings and increase satiety

The obesity crisis in the United States has now grown to epidemic proportion. And as the list of consequential health conditions and diseases continues to expand as well, there are major movements toward helping Americans lose weight.

5 Jan 2010

Study explains how semaphorin gene regulates synapse formation

By combining a research technique that dates back 136 years with modern molecular genetics, a Johns Hopkins neuroscientist has been able to see how a mammal's brain shrewdly revisits and reuses the same molecular cues to control the complex design of its circuits.

29 Dec 2009

First animal model for studying schizophrenia

Scientists have created what appears to be a schizophrenic mouse by reducing the inhibition of brain cells involved in complex reasoning and decisions about appropriate social behavior.

29 Dec 2009

Grant of $2 million awarded to understand PIGD in Parkinson's disease

The Michael J. Fox Foundation for Parkinson's Research has awarded a total of $2 million to five research teams carrying out clinical studies to refine understanding of postural instability and gait disturbances (PIGD) in Parkinson's disease, and help speed the development of urgently needed treatments.

29 Dec 2009

New research shows accurate taste perception relies on properly functioning olfactory system

As anyone suffering through a head cold knows, food tastes wrong when the nose is clogged, an experience that leads many to conclude that the sense of taste operates normally only when the olfactory system is also in good working order.

23 Dec 2009

Common variations in genes associated with microcephaly may explain differences in brain size

A group of Norwegian and American researchers have shown that common variations in genes associated with microcephaly - a neuro-developmental disorder in which brain size is dramatically reduced - may explain differences in brain size in healthy individuals as well as in patients with neurological and psychiatric disorders.

22 Dec 2009

Intra-Cellular Therapies announces results of its ITI-007 antipsychotic drug Phase I study

Intra-Cellular Therapies, Inc. (ITI) announced at a recent conference on neuropsychiatric diseases the results from a recently completed Phase I clinical study demonstrating ITI-007, the Company's lead antipsychotic drug, interacts with important targets in the living human brain. These key targets are critical to drug action in many neuropsychiatric and related disorders.

21 Dec 2009

Nexstim's Navigated Brain Stimulation System receives FDA clearance

Nexstim Oy, a medical device company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Navigated Brian Stimulation System for use in the assessment of the primary motor cortex for pre-procedural planning.

10 Dec 2009

Cell transplants may yield new therapies for dementia patients

Nerve cells transplanted into brain-damaged rats helped them to fully recover their ability to learn and remember, probably by promoting nurturing, protective growth factors, according to a new study.

10 Dec 2009

Researchers identify individualized treatments for pathological gambling

Pathological gambling can be successfully treated with medications that decrease urges and increase inhibitions, according to researchers at the annual meeting of the American College of Neuropsychopharmacology (ACNP).

10 Dec 2009

NYSE Amex to delist Cortex Pharmaceuticals

Cortex Pharmaceuticals, Inc. announced that it has received notification from the NYSE Amex LLC indicating that, due to the Company’s non-compliance with certain continued listing standards as previously reported, the Exchange intends to delist the Company’s common stock from the NYSE Amex effective as of the close of business on Friday, December 11, 2009.

9 Dec 2009

Aston University researchers receive stimulus funds to study fundamental processes of human vision

A team of researchers led by Professor Mark Georgeson and Dr Timothy Meese at Aston University in Birmingham, UK have been awarded over £1 million pounds worth of funding from the BBSRC (Biotechnology and Biological Sciences Research Council) and the EPSRC (Engineering and Physical Sciences Research Council) to investigate some of the fundamental processes involved in human vision.

8 Dec 2009

Abnormal EEG waveforms in neurological disorder patients can now be better understood

The electroencephalogram (EEG) is widely used by physicians and scientists to study brain function and to diagnose neurological disorders. However, it has remained largely unknown whether the electrodes on the head give an exact view of what is happening inside the brain.

4 Dec 2009

Cortex News and Research

Dopamine replacement therapy causes brain dysfunction in patients with Parkinson disease, study says

Reducing DA dosage causes acute withdrawal symptoms in Parkinson's patients

Functional disconnection between brain regions in ADHD children

Combination of advanced techniques in robotics and neuroscience shows promise for stroke patients

Tel Aviv University finds Mozart's music induces weight gain in premature babies

Perturbing DISC1 gene could help researchers treat mental illness, says study

Ben-Gurion University researcher defines integrated interpretation of ASD

Citicoline supplements may reduce cravings and increase satiety

Study explains how semaphorin gene regulates synapse formation

First animal model for studying schizophrenia

Grant of $2 million awarded to understand PIGD in Parkinson's disease

New research shows accurate taste perception relies on properly functioning olfactory system

Common variations in genes associated with microcephaly may explain differences in brain size

Intra-Cellular Therapies announces results of its ITI-007 antipsychotic drug Phase I study

Nexstim's Navigated Brain Stimulation System receives FDA clearance

Cell transplants may yield new therapies for dementia patients

Researchers identify individualized treatments for pathological gambling

NYSE Amex to delist Cortex Pharmaceuticals

Aston University researchers receive stimulus funds to study fundamental processes of human vision

Abnormal EEG waveforms in neurological disorder patients can now be better understood

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News